Flu News and Research

RSS

Spanish mothers more concerned about the safety of childhood vaccines

Researchers from the University of Alicante (UA) taking part in the European VACSATC project have studied mothers' and fathers' opinions on vaccinating their children in five countries. The results of the survey show that Spanish mothers are more resistant than those in other countries to the idea of paying for vaccines, while 20.9% expressed some concern about the safety of vaccines.

8 Oct 2010

CDC issues new universal influenza vaccination recommendation for all Americans

With the influenza vaccine already available and more supply anticipated than ever before, the National Foundation for Infectious Diseases convened ten of the country's leading medical and public health groups to call on all Americans to get vaccinated this season.

8 Oct 2010

Firm sees drugs sales rising 5 to 7 percent next year, other drug industry news

The Associated Press reports that global prescription drug sales should rise 5 percent to 7 percent next year reaching at least $880 billion, fueled by new drugs and rising sales in developing countries, according to drug data firm IMS Health.

8 Oct 2010

Emergent BioSolutions and TLV form new joint venture to develop flu vaccines

Emergent BioSolutions Inc., a U.S.-based developer and manufacturer of vaccines and antibody therapies, today launched its Singapore operations.

8 Oct 2010

International scientific conference explores new approaches to prevent infectious diseases

Swine flu, cancer, bioterrorism and the latest trends in countermeasures to combat these life-threatening diseases and infections are among the topics to be discussed at the upcoming New Cells for New Vaccines V: Global Perspectives international scientific conference, on October 11-13 in Wilmington, Delaware, at the Hotel du Pont.

8 Oct 2010

Study explains importance of identifying global pandemic risk factors to predict spread of diseases

A recent study led by Dr. Parviez Hosseini, a senior research fellow from EcoHealth Alliance (formerly Wildlife Trust), explains the importance of identifying global pandemic risk factors as early as possible, in order to predict the spread of diseases like H1N1 "swine" flu and SARS. "Predictive Power of Air Travel and Socio-Economic data for Early Pandemic Spread," recently published in the scientific publication PLoS ONE, examines the interplay among travel, trade, and national healthcare resources in predicting the emergence and spread of H1N1 and other viruses.

7 Oct 2010

Synthetic Genomics, JCVI announce formation of new company to develop next generation vaccines

The company Synthetic Genomics Inc. (SGI) and the not-for-profit research organization, the J. Craig Venter Institute (JCVI) today announced the formation of a new company, Synthetic Genomics Vaccines Inc. (SGVI).

7 Oct 2010

Johnson & Johnson to acquire all outstanding equity of Crucell for euro 1.75 billion

Johnson & Johnson and Crucell N.V. today announced an agreement whereby Johnson & Johnson, through an affiliate, would acquire all outstanding equity of Crucell that it does not already own for approximately euro 1.75 billion in a recommended cash tender offer.

6 Oct 2010

Altravax receives two SBIR grants for antibody-inducing vaccines research on HIV-1

Altravax, Inc. announced today that it has been awarded two SBIR grants totaling $1.2 million from the NIH's National Institute of Allergy and Infectious Diseases for research on antibody-inducing vaccines for HIV-1.

6 Oct 2010

Walgreens September sales increases 5.3% to $5.64 billion

Walgreens had September sales of $5.64 billion, an increase of 5.3 percent from $5.36 billion for the same month in fiscal 2010. Duane Reade stores, acquired in April 2010, contributed 2.8 percentage points to the total sales increase for the month.

5 Oct 2010

Liquidia commences dosing in LIQ-001 Phase 1 trial for seasonal influenza

Liquidia Technologies, a privately held nanotechnology company developing particle-based vaccines and therapeutics, today announced the initiation of human dosing of its lead vaccine product candidate, LIQ-001, in a Phase 1 clinical trial. LIQ-001, the first in a pipeline of PRINT® vaccines, is being developed as a seasonal influenza vaccine for enhanced protection in the elderly and represents the company's migration from proof of concept to the clinical application of PRINT technology.

5 Oct 2010

FMCNA offers annual flu vaccine to patients and clinical staff

Beginning in mid-October, Fresenius Medical Care North America will offer all of its patients and clinical staff an annual flu vaccine, which protects against both seasonal flu and H1N1 this year. The Centers for Disease Control (CDC) cautions that it is likely that H1N1 will continue to spread along with seasonal viruses this flu season.

5 Oct 2010

Maternal influenza vaccination prevents flu in infants

Babies whose mothers who receive influenza vaccines while pregnant appear less likely to be infected with flu or hospitalized for respiratory illnesses in their first six months of life, according to a report posted online today that will appear in the February 2011 print issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

5 Oct 2010

NIH to award $64M under Transformative Research Projects program

The National Institutes of Health will award up to $64 million over five years to encourage exploration of exceptionally innovative and original research ideas that have the potential for extraordinary impact.

4 Oct 2010

Efforts against drug-resistant malaria along Thai-Cambodian border show progress, but more 'aggressive' approach needed, health officials say

Efforts to prevent the spread of drug-resistant malaria along the border between Cambodia and Thailand are showing signs of progress, but additional work is needed to contain the new strain, health officials said on Friday, Deutsche Presse-Agentur/M&C reports.

4 Oct 2010

Healthy respect for flu this season

Flu season officially begins Friday, Oct. 1, and unlike last year's season when shortages lead to rationing, there will be plenty of vaccine on hand for everyone who wants a flu shot.

1 Oct 2010

Experts provide information on H1N1 and seasonal flu at Johns Hopkins hospital

Johns Hopkins has a wide range of experts available for interviews and comments about seasonal flu, H1N1, emergency preparedness, infection control, flu transmission in children, vaccine safety, flu treatment, public health ethics, flu in cancer patients, and related public communications strategies. If you would like to interview a Johns Hopkins expert, call or e-mail the designated information officer in the list below.

1 Oct 2010

NIH awards $3.1 million to further fund Inovio's universal SynCon flu vaccine development

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Inovio Pharmaceuticals and the University of Pennsylvania have received a grant of $3.1 million from the National Institutes of Health (NIH) Director's Office to further fund Inovio's universal SynCon™ flu vaccine development.

30 Sep 2010

Precautionary guidelines on flu vaccine safety for allergic children

With the flu season looming and health officials calling for across-the-board immunization, some parents may wonder just how safe the egg-based flu vaccine is for children with allergies. Pretty safe, say pediatricians from Johns Hopkins Children's Center: Even though the flu vaccine contains egg protein, most children with egg and other food allergies can be immunized safely with a few basic precautions.

30 Sep 2010

Austrian AGES approves Baxter's PREFLUCEL vaccine for seasonal influenza

Baxter International Inc. today announced the first approval of PREFLUCEL by the Austrian Agency for Health and Food Safety (AGES). The vaccine was shown to be effective in preventing seasonal influenza and is indicated for prophylaxis of influenza in adults and the elderly. PREFLUCEL is manufactured using Baxter's proprietary advanced Vero cell technology.

From Baxter International Inc. 30 Sep 2010

Flu News and Research

Spanish mothers more concerned about the safety of childhood vaccines

CDC issues new universal influenza vaccination recommendation for all Americans

Firm sees drugs sales rising 5 to 7 percent next year, other drug industry news

Emergent BioSolutions and TLV form new joint venture to develop flu vaccines

International scientific conference explores new approaches to prevent infectious diseases

Study explains importance of identifying global pandemic risk factors to predict spread of diseases

Synthetic Genomics, JCVI announce formation of new company to develop next generation vaccines

Johnson & Johnson to acquire all outstanding equity of Crucell for euro 1.75 billion

Altravax receives two SBIR grants for antibody-inducing vaccines research on HIV-1

Walgreens September sales increases 5.3% to $5.64 billion

Liquidia commences dosing in LIQ-001 Phase 1 trial for seasonal influenza

FMCNA offers annual flu vaccine to patients and clinical staff

Maternal influenza vaccination prevents flu in infants

NIH to award $64M under Transformative Research Projects program

Efforts against drug-resistant malaria along Thai-Cambodian border show progress, but more 'aggressive' approach needed, health officials say

Healthy respect for flu this season

Experts provide information on H1N1 and seasonal flu at Johns Hopkins hospital

NIH awards $3.1 million to further fund Inovio's universal SynCon flu vaccine development

Precautionary guidelines on flu vaccine safety for allergic children

Austrian AGES approves Baxter's PREFLUCEL vaccine for seasonal influenza

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News